The Distinguished Researcher Award, presented to Raja Mazumder, PhD, professor of biochemistry and molecular medicine.
Researchers from the George Washington University published their findings on the connection between the PTEN gene and the ARID4B gene in Nature Communications.
Hoth Therapeutics, Inc. has entered into a sponsored research agreement with GW to explore the potential use of Aprepitant for topical and/or systemic therapy to counter the dermatological related side-effects of Erlotinib therapy in cancer patients.
A team at the GW Cancer Center found that the deubiquitinating enzyme USP15 is a potential biomarker for treatments of breast and pancreatic cancers.
TESTS SHOW BP1 POSITIVE FOR 80% OF WOMEN WITH BREAST CANCER, 70% of men with prostate cancer, 63% of acute myeloid leukemia patients, 78% with non-small cell lung cancer, 47% with ovarian cancer.
BERG ALSO TO ADDRESS ROME WORLD CONGRESS ON SEPARATION SCIENCE (April 16-17)
Researchers from GW, FDA, and industry leaders published in PLOS Biology, describing a standardized communication method for researchers performing high-throughput sequencing called BioCompute.